More about the book
An in-depth look at big pharma's flagship company, this book takes readers inside Merck, the world's second most profitable drug company and maker of the bestselling drug, Prilosec. Consistently recognized by Fortune magazine as one of the Most Admired Companies, Merck faces challenges in maintaining its reputation for ethical practices amid declining profits, falling stock prices, and questionable accounting. Author Fran Hawthorne, a leading journalist in healthcare, provides a thorough examination of this business paragon, offering crucial insights into the competitive pharmaceutical landscape. The narrative appeals to both the business community and healthcare advocates by addressing vital issues in medicine today. More than just a compelling success story in a challenging industry, it thoughtfully explores significant contemporary issues and their connections to the business world. Fran Hawthorne, based in New York, serves as the Assistant Managing Editor at Crain's New York Business and has over twenty years of experience covering business for prominent publications, focusing on healthcare and pharmaceuticals. At Crain's, she leads the publication of multiple special healthcare issues each year.
Book purchase
The Merck Druggernaut, Fran Hawthorne
- Language
- Released
- 2003
- product-detail.submit-box.info.binding
- (Hardcover)
Payment methods
We’re missing your review here.
- Title
- The Merck Druggernaut
- Language
- English
- Authors
- Fran Hawthorne
- Publisher
- Wiley
- Released
- 2003
- Format
- Hardcover
- Pages
- 304
- ISBN10
- 0471228788
- ISBN13
- 9780471228783
- Series
- Tags
- Non-Fiction
- Rating
- 3.6 out of 5
- Description
- An in-depth look at big pharma's flagship company, this book takes readers inside Merck, the world's second most profitable drug company and maker of the bestselling drug, Prilosec. Consistently recognized by Fortune magazine as one of the Most Admired Companies, Merck faces challenges in maintaining its reputation for ethical practices amid declining profits, falling stock prices, and questionable accounting. Author Fran Hawthorne, a leading journalist in healthcare, provides a thorough examination of this business paragon, offering crucial insights into the competitive pharmaceutical landscape. The narrative appeals to both the business community and healthcare advocates by addressing vital issues in medicine today. More than just a compelling success story in a challenging industry, it thoughtfully explores significant contemporary issues and their connections to the business world. Fran Hawthorne, based in New York, serves as the Assistant Managing Editor at Crain's New York Business and has over twenty years of experience covering business for prominent publications, focusing on healthcare and pharmaceuticals. At Crain's, she leads the publication of multiple special healthcare issues each year.